| |
| | November 2, 2004 Study of cancer trials finds significant safety improvement |
 | | Phase 1 cancer studies are usually restricted to patients with cancer who have exhausted established therapeutic options. |
 | | For these studies, the researchers analyzed how often participants died from drug toxicity, cancer-related deaths, other toxic treatment effects, and whether or not the treatment caused the tumor to shrink, as measured by CT scanning. |
 | | Roberts' co-authors are Bernardo Goulart, MD, Bruce Chabner, MD, and Jeffrey Clark, MD of the MGH Cancer Center; Elkan Halpern, PhD, and G. Scott Gazelle, MD, MPH, PhD, of the MGH Institute of Technology Assessment; and Sarah Stallings, PhD, Stan Finkelstein, MD, and Lee Squitieri of Massachusetts Institute of Technology. |
| www.massgeneral.org /news/releases/110204roberts.html (845 words) |
|